e-learning
resources
Madrid 2019
Sunday, 29.09.2019
Nursing care across the spectrum of respiratory illnesses
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Uncontrolled asthma on GINA step 4-5 treatment increases healthcare utilization – report from the population-based OLIN-studies
C. Stridsman (Luleå, Sweden), H. Backman (Luleå, Sweden), L. Hedman (Luleå, Sweden), E. Rönmark (Luleå, Sweden)
Source:
International Congress 2019 – Nursing care across the spectrum of respiratory illnesses
Session:
Nursing care across the spectrum of respiratory illnesses
Session type:
Thematic Poster
Number:
1263
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Stridsman (Luleå, Sweden), H. Backman (Luleå, Sweden), L. Hedman (Luleå, Sweden), E. Rönmark (Luleå, Sweden). Uncontrolled asthma on GINA step 4-5 treatment increases healthcare utilization – report from the population-based OLIN-studies. 1263
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Asthma severity, poor control, co-morbidities and prior resource use determined omalizumab prescriptions in a nested case-control study with US claims data
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015
Perception of asthma control by patients: results of a survey in 5 European countries
Source: Annual Congress 2007 - Towards controlling severe asthma
Year: 2007
Characteristics of the uncontrolled asthmatic patients on GINA step 4 treatment in Korea
Source: Annual Congress 2012 - Epidemiology of asthma
Year: 2012
The impact of the addition of omalizumab on the utilization of healthcare resources by severe persistent asthma patients
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013
Reduced healthcare resource utilization in asthma patients treated with omalizumab in the clinical practice in Spain
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015
Risk factors associated to COPD worsening in Italian general practices: The 12 month COMODHES follow-up study
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014
Is asthma treatment compliance improved over the last ten years? The results of the European community respiratory health survey (ECRHS)-II
Source: Annual Congress 2004 - Asthma and allergy overtime: risks and management
Year: 2004
REG study: Real-life, longitudinal ICS adherence patterns in a UK asthma population
Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care
Year: 2015
Improvement in asthma control and reduction in medical resource use following treatment with montelukast (PRAACTICAL Study)
Source: Eur Respir J 2005; 26: Suppl. 49, 576s
Year: 2005
Effectiveness of montelukast on asthma control in infants: A claims data study
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015
Change of COPD maintenance medication over two years in a large real life cohort: The DACCORD study
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016
A national database study of the effectiveness of switching real-life asthma patients to fostair
Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis
Year: 2015
Changes in prescriped inhaled COPD medication during a 3 year period in Denmark. A registry study
Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations
Year: 2013
Cost and effectiveness of 2 years integrated care intervention in COPD
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Global asthma physician & patient (GAPP) survey: differences between treatment practice and GINA guideline recommendations in Europe – adult findings
Source: Annual Congress 2006 - New developments in the management of asthma
Year: 2006
The impact of incentives on the implementation of asthma or diabetes self-management: A systematic review
Source: International Congress 2016 – Asthma management in primary care
Year: 2016
Evaluation of a diagnostic–therapeutic pathway on GINA guidelines between specialist and primary care physicians. Study and result at 1 year in children with asthma
Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma
Year: 2008
Has asthma control improved since AIRE? Results of a survey in 5 European countries
Source: Annual Congress 2007 - Towards controlling severe asthma
Year: 2007
Prevalence of asthma and management of exacerbations in general practice (GP) after computerised Spanish guideline on the management of asthma (GEMA) and collaborative care environment
Source: International Congress 2015 – Management of asthma and COPD in primary care
Year: 2015
What clinical features underlying GINA step 1-4 drive the level of treatment in patients with asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 57s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept